|
Viromed Inc
c4-2 cell line C4 2 Cell Line, supplied by Viromed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/c4+2b+cells/pmc03680511-55-10-32 Average 90 stars, based on 1 article reviews
c4-2 cell line - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Johns Hopkins HealthCare
prostate cancer cell lines c4-2b Prostate Cancer Cell Lines C4 2b, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/c4+2b+cell+line/pm15107617-41-0-18 Average 90 stars, based on 1 article reviews
prostate cancer cell lines c4-2b - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Corning Life Sciences
c4-2b prostate cancer cells C4 2b Prostate Cancer Cells, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/c4+2b+prostate+cancer+cells/pmc05030109-135-5-30 Average 90 stars, based on 1 article reviews
c4-2b prostate cancer cells - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GemPharmatech Co Ltd
c4-2b_ enzr cells C4 2b Enzr Cells, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/c4+2b++enzr+cells/pm39696559-83-21-8 Average 90 stars, based on 1 article reviews
c4-2b_ enzr cells - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Procell Inc
human prostate cancer cell lines c4-2b ![]() Human Prostate Cancer Cell Lines C4 2b, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/human+prostate+cancer+cell+lines+c4+2b/pmc10286397-47-1-17 Average 90 stars, based on 1 article reviews
human prostate cancer cell lines c4-2b - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Charles River Laboratories
gfp-luciferase and stable shnrp2 expressing c4–2b cells ![]() Gfp Luciferase And Stable Shnrp2 Expressing C4–2b Cells, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/gfp+luciferase+and+stable+shnrp2+expressing+c4+2b+cells/pmc09979947-1098-12-39 Average 90 stars, based on 1 article reviews
gfp-luciferase and stable shnrp2 expressing c4–2b cells - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Janssen
c4-2b cells ![]() C4 2b Cells, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/c4+2b+cells/us12240790-540-0-13 Average 90 stars, based on 1 article reviews
c4-2b cells - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Federation of European Neuroscience Societies
c4-2b mdvr cells ![]() C4 2b Mdvr Cells, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/c4+2b+mdvr+cells/pm36254631-301-9-25 Average 90 stars, based on 1 article reviews
c4-2b mdvr cells - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Viromed Inc
c4 2b human prostate cancer cell line ![]() C4 2b Human Prostate Cancer Cell Line, supplied by Viromed Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c4+2b+cells/pmc08665135-34-0-9 Average 86 stars, based on 1 article reviews
c4 2b human prostate cancer cell line - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell Communication and Signaling : CCS
Article Title: ATXN3 promotes prostate cancer progression by stabilizing YAP
doi: 10.1186/s12964-023-01073-9
Figure Lengend Snippet: ATXN3 depletion decreases Hippo signaling activity in prostate cancer cells. A The siRNAs specific to each deubiquitinating enzyme were transfected into LnCap cells. After 48 h, cells were lysed and the YAP protein level was analyzed by Western blot. B , C ATXN3 depletion decreased YAP protein level. D , E ATXN3 depletion decreased YAP target genes using two different siRNA oligos. F ATXN3 depletion decreased TOP-luciferase activity. LnCap and C4-2B cells were transfected with SiATXN3 or SiControl together with YAP/TEAD-luciferase reporter plasmid. Luciferase activity was measured 48 h after transfection. G ATXN3 and YAP was upregulated in PC samples. H ATXN3 correlated YAP in human PC samples. Results shown are representative of 3 independent experiments. Data are represented as mean ± SD of biological triplicates.* P value < 0.05; ** P value < 0.01; *** P value < 0.001 by unpaired, 2-tailed Student’s t tests.
Article Snippet: The
Techniques: Activity Assay, Transfection, Western Blot, Luciferase, Plasmid Preparation
Journal: Cell Communication and Signaling : CCS
Article Title: ATXN3 promotes prostate cancer progression by stabilizing YAP
doi: 10.1186/s12964-023-01073-9
Figure Lengend Snippet: ATXN3 associates with YAP. A An immunofluorescence assay demonstrated that ATXN3 and YAP at least partially colocalized in LnCap and C4-2B cells. B Co-IP assay reveals association between endogenous ATXN3 and YAP in LnCap cells. LnCap cells were harvested with RIPA lysis buffer. Co-IP was performed using antibody as indicated. C LnCap cells transfected with Flag-ATXN3 were lysed and the lysates were incubated with GST-YAP or GST protein. The interacted ATXN3 was detected by western blot. D ATXN3 domain structure and deletion mutants used in the study. E The Josephin domain of ATXN3 interacted with YAP. HEK293 cells were transfected with 2 µg Myc-YAP together with Flag-ATXN3 full length or mutants. After 24 h, cells were harvested with NP-40 lysis buffer. Co-IP was performed using Myc antibody. The possible interacted ATXN3 domains were detected by Flag antibody. F . YAP domain structure and deletion mutants used in the study. G The WW domain of YAP interacted with ATXN3. HEK293 cells were transfected with 2 µg Flag-ATXN3 together with Myc-YAP full length or mutants. After 24 h, cells were harvested with NP-40 lysis buffer. Co-IP was performed using Flag antibody. The possible interacted YAP domains were detected by Myc antibody
Article Snippet: The
Techniques: Immunofluorescence, Co-Immunoprecipitation Assay, Lysis, Transfection, Incubation, Western Blot
Journal: Cell Communication and Signaling : CCS
Article Title: ATXN3 promotes prostate cancer progression by stabilizing YAP
doi: 10.1186/s12964-023-01073-9
Figure Lengend Snippet: ATXN3 de-polyubiquitylates YAP. A LnCap cells transfected with the indicated siRNA were treated with MG132 for 6 h before collection. YAP was immunoprecipitated with anti-YAP and immunoblotted with anti-HA. B Immunoblotting was used to detect the ubiquitination of YAP in 293 T cells co-transfected with Flag-YAP, HA-Ubiquitin and Myc-ATXN3 (wild type or C14A). C ATXN3 removed the ubiquitin chain of YAP in a dose-dependent manner. D HA-WT, K6, K11, K27, K29, K33, K48 or K63 Ub were co-transfected with Flag-YAP and Myc-ATXN3 into HEK293T cells. After treatment with 10 μM MG132 for 6 h, cell lysates were subjected to ubiquitination assay and the ubiquitination level of YAP detected by HA antibody
Article Snippet: The
Techniques: Transfection, Immunoprecipitation, Western Blot, Ubiquitin Proteomics
Journal: Cell Communication and Signaling : CCS
Article Title: ATXN3 promotes prostate cancer progression by stabilizing YAP
doi: 10.1186/s12964-023-01073-9
Figure Lengend Snippet: ATXN3 depletion inhibits prostate cancer cell proliferation, invasion stem-like properties. A, B ATXN3 depletion inhibited prostate cancer proliferation. C , D ATXN3 depletion induced G1 cell cycle arrest in prostate cancer cells. E ATXN3 depletion decreased clone formation capability of prostate cancer cells. F , G Representative images of EdU assay of prostate cancer cells. H Tranwell invasion assay of prostate cancer cells. I ATXN3 depletion decreased sphere formation of HCC cells. J ATXN3 depletion inhibits the tumor growth in vivo. C4-2B cells were stably transfected with lentivirus carrying a scrambled shRNA or ATXN3 shRNA. 1 × 10 6 LnCap cells were injected to the right dorsal flank of each mouse. Tumor sizes were measured every 5 days until the end of the experiment. K Representative images of immunohistochemical staining for Ki67, ATXN3 and YAP. (L). ATXN3 depletion suppressed the lung metastasis of ATC in mice. 0.5 × 10 6 C4-2B cells were intravenously injected into each mouse through the tail vein (n = 6). The lungs were harvested 4 weeks after injection. Results shown are representative of 3 independent experiments. Data are represented as mean ± SD of biological triplicates.* P value < 0.05; ** P value < 0.01; *** P value < 0.001
Article Snippet: The
Techniques: EdU Assay, Invasion Assay, In Vivo, Stable Transfection, Transfection, shRNA, Injection, Immunohistochemical staining, Staining
Journal: Cell Communication and Signaling : CCS
Article Title: ATXN3 promotes prostate cancer progression by stabilizing YAP
doi: 10.1186/s12964-023-01073-9
Figure Lengend Snippet: Increased YAP expression reverses the effect induced by ATXN3 depletion. A Cell proliferation assay of LnCap. B Clone formation assay of LnCap. C Representative images of EdU assay of LnCap. D Transwell invasion assay of LnCap. E Sphere formation assay of LnCap. F Overexpression of YAP in ATXN3-knockdown cells partly recovered tumor growth and lung metastasis in vivo. 1 × 10 6 C4-2B cells transfected with indicated plasmids were injected to the right dorsal flank of each mouse (n = 6). Tumor sizes were measured every 5 days until the end of the experiment. G For lung metastasis analysis, 0.5 × 10 6 C4-2B cells were intravenously injected into each mouse through the tail vein (n = 6). The lungs were harvested 4 weeks after injection. Results shown are representative of 3 independent experiments. Data are represented as mean ± SD of biological triplicates.* P value < 0.05; ** P value < 0.01; *** P value < 0.001
Article Snippet: The
Techniques: Expressing, Proliferation Assay, Tube Formation Assay, EdU Assay, Transwell Invasion Assay, Over Expression, Knockdown, In Vivo, Transfection, Injection
Journal: Oncogene
Article Title: Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer
doi: 10.1038/s41388-022-02382-y
Figure Lengend Snippet: A. A colony formation assay was performed under VEGF-C treated condition to test for sensitivity to enzalutamide following the addition of NRP2Fc. The colony formation was also analyzed with VEGF-C untreated cells. Right, bar diagrams represent the number of colonies and the relative size of the colonies under the experimental conditions. B. Schematic diagram of intratibial injection. C. micro-CT images of tumor containing bone under various condition. D-G. Bone morphometric analysis in terms of trabecular number, Trabecular thickness, Bone volume (BV)/ total volume (TV) and bone mass density (BMD) of bone under different condition. H. Analysis of tumor necrosis under various condition. I. IHC analysis for Cleaved caspase staining under different experimental condition. J. IHC for NRP2 staining under different experimental condition to show the knockdown efficiency in tumor cell. K. Schematic diagram representing how NRP2 is translocated from the plasma membrane to the nucleus of the cells to regulate TF-DNA interactions.
Article Snippet: To assess the importance of NRP2 inhibition in combination of AR-inhibition by
Techniques: Colony Assay, Injection, Micro-CT, Staining, Knockdown, Clinical Proteomics, Membrane